Cart
sales@molnova.com
BML-259
CAS No. 267654-00-2
BML-259 ( CAY10554 )
Catalog No. M28107 CAS No. 267654-00-2
BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | Get Quote |
|
| 10MG | 69 | Get Quote |
|
| 25MG | 155 | Get Quote |
|
| 50MG | 264 | Get Quote |
|
| 100MG | 462 | Get Quote |
|
| 500MG | 981 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBML-259
-
NoteResearch use only, not for human use.
-
Brief DescriptionBML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
-
DescriptionBML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.(In Vitro):BML-259 prevents a large population of cells from NAC-evoked cell death.
-
SynonymsCAY10554
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorAntifungal;Antiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number267654-00-2
-
Formula Weight260.4
-
Molecular FormulaC14H16N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=NC=C(S1)C(C)C)CC=2C=CC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Freitas-Silva O, et al. Tracing fungi secondary metabolites in Brazil nuts using LC-MS/MS. Drug Metab Lett. 2011 Aug;5(3):150-5.
molnova catalog
related products
-
[pThr3]-CDK5 Substra...
[pThr3]-CDK5 Substrate is an effective Phospho-Thr3CDK5 Substrate.[pThr3]-CDK5 Substrate is phosphorylated by CDK5 with a Km value of 6 μM.
-
MSC-2530818
MSC-2530818 (MSC 2530818, MSC2530818) is a potent, selective, and orally bioavailable CDK8 inhibitor with IC50 of 2.6 nM.
-
JH-VIII-49
JH-VIII-49 is a potent and selective inhibitor of CDK8 with IC50 of 16 nM, also inhibits CDK19 (IC50=8 nM).
